---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-25-000036"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:32:55.183715+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Halozyme appoints Cortney Caudill as COO; base salary $600K, equity award $500K

## Summary
- Cortney Caudill appointed SVP, COO effective Oct 1, 2025; previously SVP, Chief Operations Officer since Oct 2023.
- Annual base salary set at $600,000; eligible for executive incentive plans with 2025 bonus target of 50% of salary.
- Receives $500K equity award (50% stock options, 50% RSUs) vesting over four years.
- No family relationships or material interests in any transactions with the Company.

## SEC filing metadata
- accession: 0001159036-25-000036
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/0001159036-25-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/halo-20251001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-25-000036
- JSON: https://secwatch.observer/filing/0001159036-25-000036.json
- Plain text: https://secwatch.observer/filing/0001159036-25-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.